Organ Dysfunction in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors

Background Real‐world data enables evaluation of immune checkpoint inhibitor (ICI) use in advanced melanoma management. We examined characteristics and outcomes of ICI‐treated patients with advanced melanoma and organ dysfunction (baseline and emergent). Materials and Methods This retrospective obse...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The oncologist (Dayton, Ohio) Ohio), 2020-11, Vol.25 (11), p.e1753-e1762
Hauptverfasser:	Spillane, Susan, Baxi, Shrujal, Torres, Aracelis Z., Lenis, David, Freedman, Andrew N., Mariotto, Angela B., Sharon, Elad
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Combined Modality Therapy Female Humans Immune Checkpoint Inhibitors Immunotherapy Liver impairment Male Melanoma Melanoma - complications Melanoma - drug therapy Melanoma and Cutaneous Malignancies Multiple Organ Failure Renal impairment Retrospective Studies Skin Neoplasms - complications Skin Neoplasms - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!